Drug interactions between clonazepam and Trileptal
Results for the following 2 drugs: |
|
|---|---|
| clonazepam | |
| Trileptal (oxcarbazepine) | |
Interactions between your selected drugs
clonazepam ⇔ oxcarbazepine
Applies to: clonazepam and Trileptal (oxcarbazepine)
MONITOR: Based on in vitro data, coadministration with oxcarbazepine may decrease the plasma concentrations of drugs that are substrates of the CYP450 3A4 and 3A5 isoenzymes. The mechanism is accelerated clearance due to induction of CYP450 3A activities by oxcarbazepine. In one study, a single dose of oxcarbazepine (600 mg) had no effect on the pharmacokinetics of felodipine, a CYP450 3A4 substrate, while repeated doses (450 mg twice a day) decreased the peak plasma concentration and area under the concentration-time curve of felodipine (10 mg once daily) by 34% and 28%, respectively. Likewise, in a single case study, cyclosporine trough concentrations decreased to subtherapeutic levels a little over 2 weeks after addition of oxcarbazepine in a renal transplant patient. These results indicate that enzymatic induction occurs after multiple doses.
MANAGEMENT: Caution is advised if oxcarbazepine must be used concurrently with medications that undergo metabolism by CYP450 3A4 and/or 3A5, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever oxcarbazepine is added to or withdrawn from therapy.
See also...
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
